This Tuesday, Bayer, the world's largest German multinational pharmaceutical company, indicated in a statement that it intends to resolve the Roundup herbicide case related to its chemical subsidiary Monsanto with a settlement of $7.2 billion.

Since the acquisition of Monsanto in the year Since 2018, Bayer has faced thousands of lawsuits related to Roundup, in which customers claim the herbicide has caused cases of non-Hodgkin lymphoma. Although the pharmaceutical company accepted the settlement payment in its statement, this does not include an admission of liability or any wrongdoing on its part. However, if the court approves the settlement, Monsanto will have to make annual payments to the affected individuals for at least 21 years. Furthermore, people exposed to the herbicide and diagnosed with this type of cancer before the announcement of this latest ruling will be able to file their compensation claims. For its part, Bayer would be assuming between 7.8 and 11.8 billion euros in litigation liabilities, which represents approximately $9.2 to $13.9 billion. While this is not the first time Bayer has settled a lawsuit with a substantial sum of money for Monsanto products, it notes that Roundup is still on sale, both online and in retail stores, since, according to the pharmaceutical company, the herbicide is safe and its chemicals are approved.